Smith & Nephew plc
Company Snapshot
Company Overview
Smith+Nephew is a MedTech company that offers solutions to repair, regenerate, and replace soft and hard tissue. It conducts business through three segments: orthopedics, sports medicine, ENT, and advanced wound management. It caters to the tissue engineering and regeneration market through the advanced wound management, sports medicine, and ENT segments. Advanced wound management offers a comprehensive portfolio of products and services tailored to address the diverse and complex clinical needs of wound healing. The segment provides dressing, wound bioactives, and advanced wound devices. In tissue engineering, the company offers skin substitutes, including Grafix, Stravix, and Oasis, designed to aid in the healing of acute and chronic wounds, burns, and surgical applications. The sports medicine and ENT segment offers various implants that serve as scaffolds to aid tendon and cartilage healing.
Financial Highlights (FY 2025)
This information is available for BCC Research members only.
Smith & Nephew plc In News
Company's Business Segments
- Orthopaedics : Knee Implants, Hip Implants, Other Reconstruction that includes (robotics capital sales, our joint navigation business and bone cement), and Trauma & Extremities
- Sports Medicine & ENT : Sports Medicine Joint Repair, Arthroscopic Enabling Technologies, ENT (Ear, Nose and Throat)
- Advanced Wound Management : Advanced Wound Care, Advanced Wound Bioactives, Advanced Wound Devices
Applications/End User Industries
- Orthopaedic Surgeons
- Clinicians
- General Practitioners
- Healthcare Insurers
- Healthcare customers
- Purchasing professionals in hospitals